弘業期貨(03678.HK):林繼陽退任公司獨立非執行董事
格隆匯12月23日丨弘業期貨(03678.HK)公吿,於股東於臨時股東大會上批准後,周勇先生、周劍秋女士、薛炳海先生、姜琳先生、單兵先生、王躍堂先生及黃德春先生已獲重選為第四屆董事會董事,及盧華威先生已獲委任為第四屆董事會董事。其中,周勇先生及周劍秋女士已獲委任為執行董事、薛炳海先生、姜琳先生及單兵先生已獲委任為非執行董事;及王躍堂先生、黃德春先生及盧華威先生已獲委任為獨立非執行董事。
在臨時股東大會後於2021年12月23日舉行的第四屆監事會第一次會議上,虞虹女士獲選為第四屆監事會主席。由於林繼陽先生的任期於第三屆董事會屆滿截止,林先生於臨時股東大會結束時退任公司獨立非執行董事。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.